Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/27649
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGhahremani, M-
dc.contributor.authorSmith, EE-
dc.contributor.authorChen, H-Y-
dc.contributor.authorCreese, B-
dc.contributor.authorGoodarzi, Z-
dc.contributor.authorIsmail, Z-
dc.date.accessioned2023-11-16T15:09:21Z-
dc.date.available2023-11-16T15:09:21Z-
dc.date.issued2023-03-01-
dc.identifierORCID iD: https://orcid.org/0000-0001-6490-6037-
dc.identifiere12404-
dc.identifier.citationGhahremani, M. et al. (2023) 'Vitamin D supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive status', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 15 (1), e12404, pp. 1 - 11. doi: 10.1002/dad2.12404.en_US
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/27649-
dc.descriptionSupporting Information is available online at: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/dad2.12404#support-information-section .en_US
dc.description.abstractCopyright © 2023 The Authors. Introduction: Despite the association of vitamin D deficiency with incident dementia, the role of supplementation is unclear. We prospectively explored associations between vitamin D supplementation and incident dementia in 12,388 dementia-free persons from the National Alzheimer's Coordinating Center. Methods: Baseline exposure to vitamin D was considered D+; no exposure prior to dementia onset was considered D−. Kaplan–Meier curves compared dementia-free survival between groups. Cox models assessed dementia incidence rates across groups, adjusted for age, sex, education, race, cognitive diagnosis, depression, and apolipoprotein E (APOE) ε4. Sensitivity analyses examined incidence rates for each vitamin D formulation. Potential interactions between exposure and model covariates were explored. Results: Across all formulations, vitamin D exposure was associated with significantly longer dementia-free survival and lower dementia incidence rate than no exposure (hazard ratio = 0.60, 95% confidence interval: 0.55–0.65). The effect of vitamin D on incidence rate differed significantly across the strata of sex, cognitive status, and APOE ε4 status. Discussion: Vitamin D may be a potential agent for dementia prevention. Highlights: * In a prospective cohort study, we assessed effects of Vitamin D on dementia incidence in 12,388 participants from the National Alzheimer's Coordinating Center dataset. * Vitamin D exposure was associated with 40% lower dementia incidence versus no exposure. * Vitamin D effects were significantly greater in females versus males and in normal cognition versus mild cognitive impairment. * Vitamin D effects were significantly greater in apolipoprotein E ε4 non-carriers versus carriers. * Vitamin D has potential for dementia prevention, especially in the high-risk strata.en_US
dc.description.sponsorshipThe NACC database is funded by NIA/NIH grant U24-AG072122. NACC data are contributed by the NIA-funded ADRCs: P30-AG019610 (PI Eric Reiman, MD), P30-AG013846 (PI Neil Kowall, MD), P50-AG008702 (PI Scott Small, MD), P50-AG025688 (PI Allan Levey, MD, PhD), P50-AG047266 (PI Todd Golde, MD, PhD), P30-AG010133 (PI Andrew Saykin, PsyD), P50-AG005146 (PI Marilyn Albert, PhD), P50-AG005134 (PI Bradley Hyman, MD, PhD), P50-AG016574 (PI Ronald Petersen, MD, PhD), P50-AG005138 (PI Mary Sano, PhD), P30-AG008051 (PI Thomas Wisniewski, MD), P30-AG013854 (PI Robert Vassar, PhD), P30-AG008017 (PI Jeffrey Kaye, MD), P30AG010161 (PI David Bennett, MD), P50 AG047-366 (PI Victor Henderson, MD, MS), P30-AG010129 (PI Charles DeCarli, MD), P50-AG016573 (PI Frank LaFerla, PhD), P50-AG005131 (PI James Brewer, MD, PhD), P50-AG023501 (PI Bruce Miller, MD), P30-AG035982 (PI Russell Swerdlow, MD), P30-AG028383 (PI Linda Van Eldik, PhD), P30-AG053760 (PI Henry Paulson, MD, PhD), P30-AG010124 (PI John Trojanowski, MD, PhD), P50-AG005133 (PI Oscar Lopez, MD), P50-AG005142 (PI Helena Chui, MD), P30-AG012300 (PI Roger Rosenberg, MD), P30-AG049638 (PI Suzanne Craft, PhD), P50-AG005136 (PI Thomas Grabowski, MD), P50-AG033514 (PI Sanjay Asthana, MD, FRCP), P50-AG005681 (PI John Morris, MD), P50-AG047270 (PI Stephen Strittmatter, MD, PhD). Zahinoor Ismail is by the Canadian Institutes of Health Research (BCA2633). Maryam Ghahremani is supported by the Mathison Centre Postdoctoral Fellowship in Mental Health at the University of Calgary, Canada. This study was supported by the National Institute for Health and Care Research Exeter Biomedical Research Centre.en_US
dc.format.extent1 - 11-
dc.format.mediumElectronic-
dc.languageEnglish-
dc.language.isoen_USen_US
dc.publisherWiley on behalf of Alzheimer's Association.en_US
dc.rightsCopyright © 2023 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectapolipoprotein E ε4 statusen_US
dc.subjectclinical cognitive diagnosisen_US
dc.subjectCox proportional hazards modelen_US
dc.subjectdementiaen_US
dc.subjectmodifiable risk factorsen_US
dc.subjectsexen_US
dc.subjectsurvival analysisen_US
dc.subjectvitamin D deficiencyen_US
dc.subjectvitamin D supplementationen_US
dc.titleVitamin D supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive statusen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1002/dad2.12404-
dc.relation.isPartOfAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring-
pubs.issue1-
pubs.publication-statusPublished-
pubs.volume15-
dc.identifier.eissn2352-8729-
dc.rights.holderThe Authors-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2023 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.1.02 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons